Northwestern Medicine investigators have discovered new intracellular mechanisms that help specialized immune cells adapt and ...

During the second half of 2025, Werewolf plans to present interim data from the monotherapy and combination expansion arms, including tolerability, response rate, and durability, and to engage with ...

Trials of IFx-Hu2.0 are initiating, looking to overcome checkpoint inhibitor resistance in Merkel cell carcinoma.

Let us delve into some of the TLR agonists in the clinic and why the careful selection of these drugs is crucial.

Utah has the highest rate of melanoma skin cancer in the nation, according to the National Cancer Institute. Intermountain ...

The majority of patients with advanced melanoma who stop treatment with immune checkpoint inhibitor therapies remain relapse-free.

No more IV drips, cancer patients on immunotherapy can now take the drug in a single injection. The National Health Service ...

Study Identifies Subtypes of Fibroblasts in Skin Cancer Nov. 19 ... melanoma treated with a combination of immune checkpoint inhibitors survive cancer-free for 10 years or ...

as well as delayed onset of immune-related adverse events across both treatment types, as well as delayed development of metastatic disease in seropositive patients. In cutaneous melanoma ...

It had been hoped that RA patients might actually benefit more from these drugs, known as immune checkpoint inhibitors (ICIs), but that was not the case. Still, according to researchers led by Deanna ...

This innovative approach challenges the standard treatment path for many cancer patients, which typically includes surgery followed by chemotherapy and radiation. For patients facing difficult ...

Aulostm Bioscience, an immuno-oncology company working to revolutionize cancer care through development of its lead immune-activating antibody therapeutic ... whose tumors had progressed through prior ...